Partial Agonism: How Is It Thought to Work and What Is the Potential Clinical Relevance?

Understanding the neurotransmitter mechanisms thought to underlie the effects of medications used in treating mood disorders, including major depressive disorder (MDD), bipolar I disorder (BP-1), and schizophrenia, can help healthcare professionals make informed treatment decisions and manage patients’ symptoms.

Download

Recommended on NP Psych Navigator

NP Perspectives

Introduction to Bipolar Disorder Video

Tina Matthews Hayes, DNP, FNP, PMHNP provides an overview of bipolar disorder, including common symptoms and the value of earning your patient’s trust.

Clinical Article

Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

This retrospective study by Jain et al aimed to assess the use of atypical antipsychotics as first add-on treatment vs later add-on treatment in patients with MDD and to evaluate the potential impact of atypical antipsychotic line of therapy (LOT) on healthcare resource utilization (HCRU).

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.

Recommended on NP Psych Navigator

Introduction to Bipolar Disorder Video

Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

SF-12 Health Survey (SF-12v2)

SF-12 Health Survey (SF-12v2)

Welcome To NP Psych Navigator

You are now leaving NP Psych Navigator